Rinuagene Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $29.1M

  • Investors
  • 3

Rinuagene General Information

Description

Manufacturer of mRNA-based therapeutics and vaccines intended to address major global health challenges by advancing innovative oncology and infectious disease treatments. The company offers proprietary linear and circular mRNA modalities, advanced LNP-targeted delivery platforms, and AI-enabled design capabilities, enabling biomedical researchers and pharmaceutical developers to accelerate the creation of transformative RNA medicines that improve human health.

Contact Information

Website
rinuagene.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 201, Building 24, Area C, Phase II, Biomedical Industrial Park
  • Suzhou Biomedical Industrial Park, Number 218 Sangtian Street
  • Suzhou, Jiangsu 215000
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Drug Delivery
Corporate Office
  • Unit 201, Building 24, Area C, Phase II, Biomedical Industrial Park
  • Suzhou Biomedical Industrial Park, Number 218 Sangtian Street
  • Suzhou, Jiangsu 215000
  • China
+86 0512

Rinuagene Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rinuagene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 20-Apr-2026 $29.1M Completed Generating Revenue
2. Early Stage VC (Series A) 07-Mar-2024 Completed Generating Revenue
1. Early Stage VC 26-Feb-2023 $14.7M $14.7M Completed Generating Revenue
To view Rinuagene’s complete valuation and funding history, request access »

Rinuagene Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Qingdao Caitong Group Government Minority
Chang'an Capital Venture Capital Minority
K2VC Venture Capital Minority
To view Rinuagene’s complete investors history, request access »

Rinuagene FAQs

  • When was Rinuagene founded?

    Rinuagene was founded in 2021.

  • Where is Rinuagene headquartered?

    Rinuagene is headquartered in Suzhou, China.

  • What industry is Rinuagene in?

    Rinuagene’s primary industry is Drug Discovery.

  • Is Rinuagene a private or public company?

    Rinuagene is a Private company.

  • What is Rinuagene’s current revenue?

    The current revenue for Rinuagene is .

  • How much funding has Rinuagene raised over time?

    Rinuagene has raised $43.8M.

  • Who are Rinuagene’s investors?

    Qingdao Caitong Group, Chang'an Capital, and K2VC have invested in Rinuagene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process